LENSAR Inc. (LNSR)
LNSR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1320350/000119312526134587/0001193125-26-134587-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LNSR on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001320350 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $58.4M |
| Net income | -$34.3M |
| Operating income | -$24.6M |
| Net margin | -58.7% |
| Operating margin | -42.1% |
| Revenue growth | +9.2% |
| Cash | $13.0M |
| Total assets | $71.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $12.6M cash; operating cash flow -$1.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 12,294,241 (2026-10-31); 11,944,546 a year earlier; 11,248,507 three years earlier. | Cover page 2026-10-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Raleigh, North Carolina, United States | PCAOB Form AP 2026-04-08 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $14.1M | -$4.7M | -$866K | $12.6M | No debt tags | $60.1M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $16.5M | $3.5M | -$127K | $13.6M | No debt tags | $60.3M | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | $13.4M | $36.3M | -$4.3M | $12.5M | No debt tags | $57.7M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $16.0M | -$1.5M | $618K | $13.0M | No debt tags | $58.4M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $14.3M | -$3.7M | -$3.5M | $7.6M | No debt tags | $59.1M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $13.9M | -$1.8M | -$5.0M | $7.2M | No debt tags | $58.4M | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | $14.2M | -$27.3M | -$6.9M | $19.5M | No debt tags | $57.1M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $16.7M | -$18.7M | $3.7M | $16.3M | No debt tags | $53.5M | 10-K 2026-03-31 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-08-11 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEFA14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 331 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.3% |
| 1 month | -20.3% |
| 3 months | -39.5% |
| Year to date | -57.0% |
| 1 year | -51.2% |
| From 52-week high | -60.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QTEX | QTREX Quantum Ltd. | $1.15 | -8.00% | $64.4M |
| LUCD | Lucid Diagnostics Inc. | $0.3978 | -11.42% | $82.3M |
| DXR | Daxor Corporation | $8.36 | -0.89% | $48.8M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| ADGM | Adagio Medical Holdings Inc | $1.61 | -16.58% | $44.2M |
| MBOT | Microbot Medical Inc. | $0.6444 | -34.16% | $43.3M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier